• P-ISSN 0974-6846 E-ISSN 0974-5645

Indian Journal of Science and Technology


Indian Journal of Science and Technology

Year: 2020, Volume: 13, Issue: 48, Pages: 4739-4745

Original Article

Critical cases of COVID-19 patients can be predicted by the biomarkers of complete blood count

Received Date:09 November 2020, Accepted Date:12 December 2020, Published Date:07 January 2020


Background: The confirmatory test for COVID-19 relies on the virus levels in the patients and sampling methods. Besides, there is no definitive description of the role of diagnostic lab parameters in the analysis of positive cases yet. Objective: To investigate the positive COVID-19 cases by screening out hematological biomarker for detection of disease severity and progression. Methods: Data of 110 confirmed COVID-19 cases at King Abdulaziz hospital were analyzed, 42 (38.2%) of the cases were treated in ICU. All variables’ means and variances were compared between two groups (non-severe patients and severe) using statistical analysis. Results: ICU and non-ICU positive cases rates were 38.2% and 61.8% respectively. Out of COVID-19 patients, 60% showed lymphopenia and neutrophilia (P < 0.025) and Eosinopenia (60.9%). Furthermore, low levels of MCH and hemoglobin were observed in 96.4% and 90%, respectively. At a significance level of 5%, statistical tests showed a statistically significant difference between groups under investigation in both the mean value and variance for lymphocyte, neutrophils, platelet, and WBCs variables. Conclusions: The analysed variables can be used for predicting patients with positive COVID-19 cases. Lymphocytes and neutrophils were much helpful in monitoring disease severity and infection progression. Moreover, these results encourage considering data as a useful, rapid, and easy way to arrive at a decision of disease severity.

Keywords: CBC; Laboratory biomarker; COVID-19; Lymphopenia; Eosinopenia


  1. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395:565–574. Available from: https://doi.org/10.1016/S0140-6736(20)30251-8
  2. Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W, et al. Correlation of Chest CT and RT-PCR testing for Coronavirus disease 2019 (COVID-19) in China: A report of 1014 cases. Radiology. 2020;296(2):E32–E40. Available from: https://dx.doi.org/10.1148/radiol.2020200642
  3. Yang Y, Yang M, Shen C, Wang F, Yuan J, Li J. 2020. Available from: https://doi.org/10.1101/2020.02.11.20021493
  4. Frater JL, Zini G, d’Onofrio G, Rogers HJ. COVID‐19 and the clinical hematology laboratory. International Journal of Laboratory Hematology. 2020;42(S1):11–18. Available from: https://dx.doi.org/10.1111/ijlh.13229
  5. Katipoğlu B, Sönmez LÖ, Vatansev H, Yüce N, Sabak M, Szarpak L, et al. Can hematological and biochemical parameters fasten the diagnosis of COVID-19 in emergency departments? Disaster and Emergency Medicine Journal. 2020. Available from: https://dx.doi.org/10.5603/demj.a2020.0039
  6. Mardani R, Vasmehjani A, Zali A, Gholami F, A, Nasab M, et al. Laboratory Parameters in Detection of COVID-19 Patients with Positive RT-PCR; a Diagnostic Accuracy Study. Arch Acad Emerg Med. 2020;8(1):43.
  7. Yang AP, Liu JP, Tao WQ, et al. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. Int Immunopharmacol. 2020;84.
  8. Suna S, Caib X, Wang H, He G, Lin Y, Lu B, et al. Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China. Clinica Chimica Acta. 2020;507:174–180.
  9. Lindsley AW, Schwartz JT, Rothenberg ME. Eosinophil responses during COVID-19 infections and coronavirus vaccination. Journal of Allergy and Clinical Immunology. 2020;146(1):1–7. Available from: https://dx.doi.org/10.1016/j.jaci.2020.04.021
  10. Chen R, Sang L, Jiang M, Yang Z, Jia N, Al ET. Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China. Journal of Allergy and Clinical Immunology. 2020;146:89–100.
  11. Liu F, Xu A, Zhang Y, Xuan W, Yan T, Pan K, et al. Patients of COVID-19 may benefit from sustained Lopinavir-combined regimen and the increase of Eosinophil may predict the outcome of COVID-19 progression. International Journal of Infectious Diseases. 2020;95:183–191. Available from: https://dx.doi.org/10.1016/j.ijid.2020.03.013
  12. Grasselli G, Greco M, Zanella A. Risk Factors Associated with Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy. JAMA Internal Medicine. 2020;180(10):1345–1355.
  13. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China. Lancet. 2020;395:497–506.
  14. Fu J, Kongd J, Wange W, Wub M, Yaob L, Wangc Z, et al. The clinical implication of dynamic neutrophil to lymphocyte ratio and Ddimer in COVID-19: A retrospective study in Suzhou China. Thrombosis Research. 2020;192:3–8.
  15. Lippi G, Simundic AM, Plebani M. Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19) Clinical Chemistry and Laboratory Medicine (CCLM). 2020;58(7):1070–1076. Available from: https://dx.doi.org/10.1515/cclm-2020-0285


© 2020 Attiyah et al.This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Published By Indian Society for Education and Environment (iSee)


Subscribe now for latest articles and news.